Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation

Human Pathology

Volumn 27, Issue 1, 1996, Pages 20-27

  Gulley, Margaret L ^a   Pulitzer, Donald R ^b   Eagan, Phyllis A ^b   Schneider, Barbara G ^b  

^a University of Texas Health Science Center   (United States)

^b NONE

Author keywords

bcl 2; Epstein Barr virus; gastric carcinoma; Hispanic; p53

Indexed keywords

ONCOPROTEIN; PROTEIN P53; VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; ONCOGENE; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; VIRUS INFECTION;

EID: 0030059355     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90133-1     Document Type: Article

References (62)

1. Weiss LM, Mohaved LA, Butler AE, et al: Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for EBV genomes by in situ hybridization. Am J Surg Pathol 13:625-631, 1989
2. Iezzoni JC, Gaffey MJ, Weiss LM: The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol 103:308-315, 1995
3. Pittaluga S, Wong MP, Chung LP, et al: Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol 17:678-682, 1993
4. Niedobitek G, Hansmann ML, Herbst H, et al: Epstein-Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cells carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 165:17-24, 1991
5. Wu TC, Kuo TT: Study of Epstein-Barr virus early RNA-1 (EBER1) expression by in situ hybridization in thymic epithelial tumors of Chinese patients in Taiwan. HUM PATHOL 24:235-238, 1993
6. Shibata D, Tokunaga M, Uemura Y, et al: Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Am J Pathol 139:469-474, 1991
7. Shousha S, Lumqmani YA: Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa. J Clin Pathol 47:695-698, 1994
8. Leoncini L, Vincioni C, Megha T, et al: Epstein-Barr virus and gastric cancer: Data and unanswered questions. Int J Cancer 53:898-901, 1993
9. Burke AP, Yen TS, Shekitka KM, et al: Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 3:377-380, 1990
10. Mori M, Watanabe M, Tanaka S, et al: Epstein-Barr virus-associated carcinomas of the esophagus and stomach. Arch Pathol Lab Med 118:998-1001, 1994
11. Niedobitek G, Herbst H, Young LS, et al: Epstein-Barr virus and carcinomas. Diagn Mol Path 2:103-108, 1992
12. Takano Y, Kato Y, Sugano H: Epstein-Barr-virus-associated medullary carcinomas with lymphoid infiltration of the stomach. J Cancer Res Clin Oncol 120:303-308, 1994
13. Harn H-J, Chang J-Y, Wang M-W, et al: Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. HUM PATHOL 26:267-271, 1995
14. Min K-W, Holmquist S, Peiper SC, et al: Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas of the stomach): Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction. Am J Clin Pathol 96:219-226, 1991
15. Ott G, Kirchner TH, Muller-Hermelink HK: Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology 25:323-329, 1994
16. Pittaluga S, Loke SL, So KC, et al: Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the stomach: Demonstration of viral genome by in situ hybridization and Southern blot analysis. Mod Pathol 5:661-664, 1992
17. Rowlands DC, Ito M, Mangham DC, et al: Epstein-Barr virus and carcinomas: Rare association of the virus with gastric adenocarcinomas. Br J Cancer 68:1014-1019, 1993
18. Shibata D, Hawes D, Stemmermann GN, et al: Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 2:213-217, 1993
19. Yuen ST, Chung LP, Leung SY, et al: In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Surg Pathol 18:1158-1163, 1994
20. Tokunaga M, Uemura Y, Tokudome T, et al: Epstein-Barr virus related gastric cancer in Japan: A molecular pathoepidemiological study. Acta Pathol Jpn 43:574-581, 1993
21. Shibata D, Weiss LM: Epstein-Barr virus-associated gastric carcinoma. Am J Pathol 140:769-774, 1992
22. Imai S, Koizumi S, Suguira M, et al: Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131-9135, 1994
23. Tokunaga M, Land CE, Uemura Y, et al: Epstein-Barr virus in gastric carcinoma. Am J Pathol 143:1250-1254, 1993
24. Levine PH, Stemmermann G, Lennette ET, et al: Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr virus associated gastric adenocarcinoma. Int J Cancer 60:642-644, 1995
25. Shiao Y-H, Rugge M, Correa P, et al: p53 alteration in gastric precancerous lesions. Am J Pathol 144:511-517, 1994
26. Zhang Q, Gutsch D, Kenney S: Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency. Mol Cell Biol 14:1929-1938, 1994
27. Szekely L, Selivanova G, Magnusson K, et al: EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A 90:5455-5459, 1993
28. Henderson S, Rowe M, Gregory C, et al: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115, 1991
29. Lu Q-L, Elia G, Lucas S, et al: Bcl-2 protooncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 53:29-35, 1993
30. Texas Department of Health: Texas cancer incidence data (1976-1985)
31. Howson CP, Hiyama T, Wydner EL: The decline in gastric cancer: Epidemiology of an unplanned triumph. Epidemial Rev 8:1-27, 1986
32. Schneider BG, Hilsenbeck SG, Hensel CH, et al: p53 Mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos. Virchous Arch Pathol 424:187-193, 1994
33. Gulley ML, Eagan PA, Quintanilla-Martinez L, et al: Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and Hispanic American ethnicity. Blood 6:1595-1602, 1994
34. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma: An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64:31-49, 1965
35. Gulley ML, Raab-Traub N: Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med 117:1115-1120, 1993
36. Ambinder RF, Mann RB: Epstein-Barr encoded RNA in situ hybridization: Diagnostic applications. HUM PATHOL 25:602-605,1994
37. Andersen J, Zieve GW: Assembly and intracellular transport of snRNP particles. Bioessays 13:57-64, 1991
38. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889, 1986
39. Elias JM, Margiotta M, Gaborc O: Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC) and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol 92:62-67, 1989
40. Rowe M, Evans H, Young L, et al: Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression on virus-transformed cells. J Gen Virol 68P:1575-1586, 1987
41. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al: Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphomas. J Pathol 165:289-299, 1991
42. Harrell FE: The LOGIST procedure, SAS/STAT User's Guide, Release 6.04. Gary, NC, SAS Institute, 1990, pp 175-230
43. Durrelman S, Simon R: Flexible regression models with cubic splines. Stat Med 8:551-561, 1989
44. The PHREG procedure, in SAS Technical Report P-229. Cary, NC, SAS Institute, 1992, pp 435-479
45. Horiuchi K, Mishima K, Ohsawa M, et al: Carcinoma of stomach and breast with lymphoid stroma: Localization of Epstein-Barr virus. J Clin Pathol 47:538-540, 1994
46. Watanabe H, Enjoji M, Imai T: Gastric carcinomas with lymphoid stroma: Its morphologic characteristics and clinical prognosis. Cancer 38:232-243, 1976
47. Nakamura S, Ueki T, Yao T, et al: Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Cancer 73:2239-2249, 1994
48. Krajewski S, Bodrug S, Gascoyne R, et al: Immunohistochemical analysis of mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 145:515-525, 1994
49. Correa P: Precursors of gastric and esophageal cancer. Cancer 50:2554-2565, 1982
50. Correa P: A human model of gastric carcinogenesis. Cancer Res 48:3554-3560, 1988
51. Pathmanathan R, Prasad U, Sadler R, et al: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693-698, 1995
52. Yeung WM, Zong YS, Chiu CT, et al: Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 53:746-750, 1993
53. Sam CK, Brooks LA, Niedobitek G, et al: Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinomas. Int J Cancer 53:957-962, 1993
54. Fukunaga M, Monden T, Nakanishi H, et al: Immunohistochemical study of p53 in gastric carcinoma. Am J Clin Pathol 101:177-180, 1994
55. Farrell PJ, Allan GJ, Shanahan F, et al: p53 Is frequently mutated in Burkitt's lymphoma cell lines. EMBOJ 10:2879-2887, 1991
56. Niedobitek G, Agathanggelou A, Barber P, et al: p53 Overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 170:457-461, 1993
57. Effert P, McCoy R, Abdel-Hamidi M, et al: Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 66:3768-3775, 1992
58. Suzukii T, Takano Y, Yamashita K, et al: A possible role for Epstein-Barr virus in tumorigenesis after immunosuppression in cases of renal transplantation. J Cancer Res Clin Oncol 119:627-629, 1993
59. Li QX, Young LS, Niedobitek G, et al: Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 356:347-350, 1992
60. Finke J, Fritzen R, Ternes P, et al: Expression of bcl-2 in Burkitt's lymphoma cell lines: Induction by latent Epstein-Barr virus genes. Blood 80:459-469, 1992
61. Khan G, Gupta RK, Coates PJ, et al: Epstein-Barr virus infection and bcl-2 protooncogene expression: Separate events in the pathogenesis of Hodgkin's disease? Am J Pathol 143:1270-1274, 1993
62. Tao Q, Srivastava G, Loke SL, et al: Lack of correlation between expression of Epstein-Barr virus (EBV) latent membrane protein and bcl-2 oncoprotein expression in vivo. J Clin Pathol 47:589-591, 1994